Specifically, the study revealed that an increase in tertiary lymphoid structures within tumor lesions enhanced synergy between B cells and CD4+ T cells and that the conversion of B cells into an anti-tumor IgG class significantly amplified the anti-tumor immune response [52]. This evidence concerns the gene CD4 and neoplasm.